Abstract
Advanced drug delivery systems present indubitable advantages for drug administration. During the past three decades, new approaches for the development of new carriers for this topic have been suggested. This led to explosion of publication activity in the area. This article reviews briefly the history of the topic and focuses on general concepts in the issue. One of the most crucial properties of advanced delivery systems is their ability to be well controlled in terms of a carrier structure which is responsible for an optimal drug release. Here we describe new polymerization technologies which consider this particular aspect. A special attention is paid to the preparation of materials by LRP (Living Radical Polymerization) and perspectives of its practical application to the treatment of single diseases. Due to the epidemic scale of Diabetes mellitus, novel drug delivery systems play an important role in and are highly relevant for improved treatment of worldwide permanently growing sub-population of diabetic patients. Type 1 is the insulin-dependent diabetes which accounts for 5 till 10 percent of the whole pool of diabetic cases and currently attracts main attention in research activity devoted to the development of advanced drug delivery systems. Minimal invasive insulin administration approaches and/or improvement of pancreatic activity in own insulin production is the main goal of novel drug delivery systems highly desirable for advanced treatment of diabetic patients with both type 1 and type 2 of the disease.
Keywords: Living radical polymerization, drug delivery systems, cells encapsulation, Diabetes mellitus
Infectious Disorders - Drug Targets
Title: New Approaches in Drug Delivery Systems: Application for Diabetes Treatment
Volume: 8 Issue: 2
Author(s): Jorge F. J. Coelho, Paula Ferreira and Maria H. Gil
Affiliation:
Keywords: Living radical polymerization, drug delivery systems, cells encapsulation, Diabetes mellitus
Abstract: Advanced drug delivery systems present indubitable advantages for drug administration. During the past three decades, new approaches for the development of new carriers for this topic have been suggested. This led to explosion of publication activity in the area. This article reviews briefly the history of the topic and focuses on general concepts in the issue. One of the most crucial properties of advanced delivery systems is their ability to be well controlled in terms of a carrier structure which is responsible for an optimal drug release. Here we describe new polymerization technologies which consider this particular aspect. A special attention is paid to the preparation of materials by LRP (Living Radical Polymerization) and perspectives of its practical application to the treatment of single diseases. Due to the epidemic scale of Diabetes mellitus, novel drug delivery systems play an important role in and are highly relevant for improved treatment of worldwide permanently growing sub-population of diabetic patients. Type 1 is the insulin-dependent diabetes which accounts for 5 till 10 percent of the whole pool of diabetic cases and currently attracts main attention in research activity devoted to the development of advanced drug delivery systems. Minimal invasive insulin administration approaches and/or improvement of pancreatic activity in own insulin production is the main goal of novel drug delivery systems highly desirable for advanced treatment of diabetic patients with both type 1 and type 2 of the disease.
Export Options
About this article
Cite this article as:
Coelho F. J. Jorge, Ferreira Paula and Gil H. Maria, New Approaches in Drug Delivery Systems: Application for Diabetes Treatment, Infectious Disorders - Drug Targets 2008; 8 (2) . https://dx.doi.org/10.2174/187152608784746556
DOI https://dx.doi.org/10.2174/187152608784746556 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
Call for Papers in Thematic Issues
New Frontiers in Infectious Disease Research: Small-Molecule Probes and Biomarker Identification
The biological relevance of small-molecule chemical probes targeting a disease model is crucial in the early stages of drug discovery. The integration of omics technologies such as genomics, proteomics, metabolomics, immunomic, and cellular levels has greatly enhanced the ability to identify novel biomarkers and understand the complex interactions between pathogens ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
“Actin”g on GLUT4: Membrane & Cytoskeletal Components of Insulin Action
Current Diabetes Reviews Hypertension to Heart Failure: New Developmental Strategies do not Cross a Clinical and Therapeutic Divide
Current Pharmaceutical Design Selenium in the Therapy of Neurological Diseases. Where is it Going?
Current Neuropharmacology Bitter Gourd (Momordica charantia) is a Cornucopia of Health: A Review of its Credited Antidiabetic, Anti-HIV, and Antitumor Properties
Current Molecular Medicine Conservative Management of Gestational Hypercalcemia Due to Primary Hyperparathyroidism with Lack of Complications
Endocrine, Metabolic & Immune Disorders - Drug Targets The Association of Fractalkine Receptor (T280M) Polymorphism in the Pathogenesis of Acute Coronary Syndrome in the Egyptian Population
Current Pharmaceutical Biotechnology Prognostic Relevance of Metabolic Approach in Patients with Heart Failure
Current Pharmaceutical Design Role of Connexins and Pannexins in Ischemic Stroke
Current Medicinal Chemistry Editorial [Hot Topic: Trends in Vascular Biology; Functional Restoration of Damaged Endothelium (Executive Editors: J.A. Rodriguez-Feo and G. Pasterkamp)]
Current Pharmaceutical Design Sympathetic Overactivity in Patients with Chronic Renal Failure - The Culprit of Increased Cardiovascular Mortality?
Current Hypertension Reviews Endoplasmic Reticulum Stress, Diabetes Mellitus, and Tissue Injury
Current Protein & Peptide Science Hyperuricemia and Coronary Artery Disease
Current Rheumatology Reviews The Role of Fibroblast Growth Factor 21 (FGF21) on Energy Balance, Glucose and Lipid Metabolism
Current Diabetes Reviews The Role of Islet Neogeneis-Associated Protein (INGAP) in Pancreatic Islet Neogenesis
Current Protein & Peptide Science Mechanisms of Action of Metformin in Type 2 Diabetes and Associated Complications: An Overview
Mini-Reviews in Medicinal Chemistry Metabolic Reprogramming of Human Cells in Response to Oxidative Stress: Implications in the Pathophysiology and Therapy of Mitochondrial Diseases
Current Pharmaceutical Design Protein Glycation: An Old Villain is Shedding Secrets
Combinatorial Chemistry & High Throughput Screening MTHFR Gene Polymorphism and Diabetic Retinopathy
Current Diabetes Reviews An Osteoblastic Inflammatory Redox Model, using TNF-a, Glucose and Glucose- Oxidized Low- Density Lipoprotein: Targets for Minocycline
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) <i>Nigella sativa</i> – A Functional Spice From A Pharaoh’s Tomb to Modern Healthcare
The Natural Products Journal